Overdiagnosis in screening mammography in Denmark: Population based cohort study

BMJ (Online)

Volumn 346, Issue 7901, 2013, Pages

  Njor, Sisse Helle ^a   Olsen, Anne Helene ^b   Blichert Toft, Mogens ^c   Schwartz, Walter ^d   Vejborg, Ilse ^e   Lynge, Elsebeth ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF TROMSØ   (Norway)

^c Danish Breast Cancer Cooperative Group   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e Mental Health Services CPH   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; DIAGNOSTIC ERROR; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL;

AGED; BREAST NEOPLASMS; CARCINOMA; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; COHORT STUDIES; DENMARK; DIAGNOSTIC ERRORS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED;

EID: 84875795617     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f1064     Document Type: Article

References (25)

1. Paci E, Duffy S. Overdiagnosis and overtreatment in service screening. Breast Cancer Res 2005;7:266-70.
2. Duffy SW, Lynge E, Jonsson H, Ayyaz S, Olsen AH. Complexities in the estimation of overdiagnosis in breast cancer screening. Br J Cancer 2008;99:1176-8.
3. Boer R, Warmerdam P, de Koning H, van Oortmarssen G. Extra incidence caused by mammographic screening. Lancet 1994;343:979.
4. Møller B, Weedon-Fekjaer H, Hakulinen T, Tryggvadóttir L, Storm HH, Talbäck M, et al. The influence of mammographic screening on national trends in breast cancer incidence. Eur J Cancer Prev 2005;14:117-28.
5. Biesheuvel C, Barratt A, Howard K, Houssami N, Irwig L. Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol 2007;8:1129-38.
6. Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ 2006;332:689-92.
7. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study - 1: breast cancer mortality after 11 to 16 years of follow-up. Ann Intern Med 2002;137:E305-8.
8. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study - 2: 13-year results of a randomised trial in women aged 50-59 tears. J Natl Cancer Inst 2000;92:1490-9.
9. Jensen A, Olsen AH, von Euler-Chelpin M, Njor SH, Vejborg I, Lynge E. Do nonattenders in mammography screening programmes seek mammography elsewhere? Int J Cancer 2005;113:464-70.
10. Harris RJ, Bradburn MJ, Deeks JJ, Harbord RM, Altman DG, Sterne JAC. Meta: fixed and random effects meta-analysis. Stat J 2008;8:3-28.
11. Tryggvadóttir L, Gislum M, Bray F, Klint A, Hakulinen T, Storm HH, et al. Trends in the survival of patients diagnosed with breast cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010;49:624-31.
12. Lynge E. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. APMIS Suppl 1998;83:1-44.
13. Njor SH, Olsen AH, Bellstrøm T, Dyreborg U, Bak M, Axelsson C, et al. Mammography screening in the county of Fyn November 1993-December 1999. APMIS Suppl 2003;110:1-33.
14. Johnstone PA, Norton MS, Riffenburgh RH. Survival of patients with untreated breast cancer. J Surg Oncol 2000;73:273-7.
15. Puliti D, Miccinesi G, Zappa M, Manneschi G, Crocetti E, Paci E. Balancing harms and benefits of service mammography screening programs: a cohort study. Breast Cancer Res 2012;14:R9.
16. Puliti D, Zappa M, Miccinesi G, Falini P, Crocetti E, Paci E. An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence. Eur J Cancer 2009;45:3166-71.
17. De Gelder R, Heijnsdijk EA, van Ravesteyn NT, Fracheboud J, Draisma G, de Koning HJ. Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev 2011;33:111-21.
18. National Cancer Institute, Breast Cancer Surveillance Consortium. Cancers for 2,264,089 screening mammography examinations from 2002 - 2006 - based on BCSC data as of 2009. http://breastscreening.cancer.gov/data/benchmarks/ screening/2009/table4.html.
19. Svendsen AL, Olsen AH, von Euler-Chelpin M, Lynge E. Breast cancer incidence after the introduction of mammography screening: what should be expected? Cancer 2006;106:1883-90.
20. Olsen AH, Agbaje OF, Myles JP, Lynge E, Duffy SW. Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program. Breast J 2006;12:338-42.
21. Jørgensen KJ, Zahl PH, Gøtzsche PC. Overdiagnosis in organised mammography screening in Denmark: a comparative study. BMC Womens Health 2009;9:36.
22. Zahl PH, Maehlen J, Welch HG. The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med 2008;168:2311-6.
23. Zahl PH, Gøtzsche PC, Mæhlen J. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study. Lancet Oncol 2011;12: 1118-24.
24. Weedon-Fekjær H, Sørum R, Brenn MK. Hormone therapy use may explain recent results regarding tumor regression. Arch Intern Med 2009;169:996-7.
25. Moss S. Overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res 2005;7:230-4.